Qinghai Spring Medicinal Resources Technology Co., Ltd. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was CNY 155.05 million compared to CNY 123.89 million a year ago. Revenue was CNY 160.18 million compared to CNY 127.76 million a year ago.

Net loss was CNY 287.55 million compared to CNY 248.61 million a year ago. Basic loss per share from continuing operations was CNY 0.49 compared to CNY 0.42 a year ago. Diluted loss per share from continuing operations was CNY 0.49 compared to CNY 0.42 a year ago.